Belfast-based digital health company Eolas Medical has successfully raised $12 million (£8.9 million) in Series A funding to expand its clinical decision-making knowledge platform.

Funding Details

• The funding round was led by Acton Capital.
• It aims to support growth in the UK and Ireland and facilitate international expansion of its point-of-care knowledge tools.

Platform Objectives

Eolas Medical’s web and mobile applications are designed to:

• Replace intranets and fragmented document stores with a unified source of truth.
• Provide clinicians with access to approved local guidance, policies, and medication information.

CEO’s Insights

Declan Kelly, founder and CEO of Eolas Medical, emphasized the platform’s mission:

“Eolas has always been about solving a very practical problem: giving healthcare professionals fast, reliable access to the knowledge they need, when they need it.”

He highlighted the importance of quick decision-making in acute settings, especially during high-pressure periods like winter.

AI Integration

The Eolas platform features a new AI-powered search function that allows healthcare staff to:

• Ask questions and receive answers sourced from their organization’s internal resources.
• Speed up decision-making without compromising governance or clinical oversight.

User Experience

Elisha Zafar, a specialist infection pharmacist at King’s College Hospital NHS Foundation Trust, shared her experience:

“The search function is the biggest benefit. You type in a few letters, and it searches across all the guidelines using the keywords we’ve built in. It’s really easy to find what you need.”

She noted that the platform is currently used for all infection guidelines and is being expanded to include more guidelines.

Market Presence

Eolas Medical is currently embedded in over 400 clinical sites across the UK and is utilized by 85% of NHS acute trusts.

Investor Perspective

Fritz Oidtmann, managing partner at Acton Capital, expressed enthusiasm for Eolas Medical:

“Our conversations with clinicians showed remarkable enthusiasm for Eolas. Clinicians love the product. The benefit is immediate, the value is clear.”

This funding will enable Eolas Medical to accelerate the development and global scale of its AI-powered clinical knowledge platform, enhancing its presence in the US, Europe, and other global healthcare systems.